MBRX
MBRX
NASDAQ · Biotechnology

Moleculin Biotech Inc

$8.10
+0.04 (+0.50%)
As of Nov 11, 10:19 PM ET ·
Analyst Consensus
Strong Buy
9
Analysts
Moderate
Coverage
Buy 8 89%
Hold 1 11%
Sell 0 0%
Price Target
Analyst Price Target +214.0% upside
Low Target $14.54
Average Target $25.43
High Target $32.33
Current Price $8.10
Current
$8.10
Target
$25.43
$14.54 $25.43 avg $32.33
Scenario Analysis
Bear Case
$14.54
79.5%
Low target
Base Case
$25.43
+214.0%
Avg target
Bull Case
$32.33
+299.1%
High target
Risk/Reward
3.8x
Highly favorable
Price in Context
52-Week High
$253.00
-96.8% from high
52-Week Low
$3.23
+150.8% from low
Target vs 52W High
$25.43
-89.9% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 38 82% $257.58 -12.5%
AMGN
Amgen Inc
Hold 42 43% $190.87 -59.1%
GILD
Gilead Sciences Inc
Strong Buy 36 83% $362.68 +115.9%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 82% $438.34 -19.2%
MRNA
Moderna Inc
Hold 31 32% $149.45 -35.4%
REGN
Regeneron Pharmaceuticals
Buy 36 72% $76.80 -91.9%
NTRA
Natera Inc
Strong Buy 31 90% $142.91 -55.7%
RVMD
Revolution Medicines Inc
Strong Buy 31 94% $114.11 -35.3%